After a Series of Acquisitions, Fisher Expects 2006 Sales to Grow Around 10 Percent | GenomeWeb

Fisher Scientific officials said this week that they expect their recent string of acquisitions, among other initiatives, to help 2006 sales grow by between 9 percent and 11 percent.

Fisher has been aggressive in the M&A market so far this year, acquiring four firms for more than $400 million. Following a year in which the firm purchased a total of four companies, Paul Meister, vice chairman of Fisher, said during the firm's first-quarter conference call this week, "The pace [of acquisitions] has obviously picked up."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.